NYSE:OLN - Olin Stock Price, News, & Analysis

Olin trades on the New York Stock Exchange (NYSE) under the ticker symbol "OLN."

Olin announced a quarterly dividend on Friday, January 25th. Investors of record on Monday, February 11th will be given a dividend of $0.20 per share on Monday, March 11th. This represents a $0.80 annualized dividend and a dividend yield of 3.54%. The ex-dividend date of this dividend is Friday, February 8th. View Olin's Dividend History.

Olin declared that its board has approved a share repurchase program on Tuesday, May 1st 2018, which permits the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 9.9% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

Olin Co. (NYSE:OLN) released its quarterly earnings results on Monday, February, 4th. The specialty chemicals company reported $0.32 EPS for the quarter, missing the Zacks' consensus estimate of $0.34 by $0.02. The specialty chemicals company had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.70 billion. Olin had a return on equity of 10.42% and a net margin of 4.72%. The business's quarterly revenue was up .9% on a year-over-year basis. During the same period in the prior year, the firm posted $2.89 EPS. View Olin's Earnings History.

Olin is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for Olin.

11 equities research analysts have issued twelve-month target prices for Olin's shares. Their predictions range from $20.00 to $40.00. On average, they expect Olin's stock price to reach $29.2727 in the next year. This suggests a possible upside of 29.4% from the stock's current price. View Analyst Price Targets for Olin.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Olin in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Olin.

News articles about OLN stock have been trending somewhat positive this week, InfoTrie reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Olin earned a media sentiment score of 0.6 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the near future.

Olin saw a increase in short interest in February. As of February 15th, there was short interest totalling 7,278,381 shares, an increase of 81.8% from the January 31st total of 4,003,137 shares. Based on an average daily volume of 2,742,454 shares, the short-interest ratio is presently 2.7 days. Currently, 4.4% of the shares of the stock are short sold. View Olin's Current Options Chain.

Some companies that are related to Olin include ASAHI KASEI COR/ADR (AHKSY), FMC (FMC), Johnson Matthey (JMPLY), Chemours (CC), W. R. Grace & Co (GRA), Huntsman (HUN), Ashland Global (ASH), KURARAY CO LTD/ADR (KURRY), Ingevity (NGVT), Univar (UNVR), Balchem (BCPC), GCP Applied Technologies (GCP), PQ Group (PQG), Innospec (IOSP) and KMG Chemicals (KMG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Olin investors own include General Electric (GE), AT&T (T), Exxon Mobil (XOM), Verizon Communications (VZ), Altria Group (MO), PepsiCo (PEP), IBM (IBM), AbbVie (ABBV), Procter & Gamble (PG) and Cisco Systems (CSCO).

Olin's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.60%), FMR LLC (7.42%), Dimensional Fund Advisors LP (3.20%), Macquarie Group Ltd. (2.42%), Millennium Management LLC (1.49%) and Bank of New York Mellon Corp (1.46%). Company insiders that own Olin stock include Brett A Flaugher, C Robert Bunch, Dolores J Ennico, Donald W Bogus, Earl L Shipp, John E Fischer, John L Mcintosh, John Maurice Sampson, Randall W Larrimore, Scott Mcdougald Sutton and Stephen C Curley. View Institutional Ownership Trends for Olin.

OLN stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Prudential PLC, Squarepoint Ops LLC, Manning & Napier Group LLC, Quantum Capital Management, Boston Partners, SG Americas Securities LLC and American Century Companies Inc.. Company insiders that have sold Olin company stock in the last year include Brett A Flaugher and John L Mcintosh. View Insider Buying and Selling for Olin.

OLN stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Norges Bank, Oregon Public Employees Retirement Fund, Deprince Race & Zollo Inc., Beaconlight Capital LLC, Dimensional Fund Advisors LP, BlackRock Inc. and Bank of New York Mellon Corp. Company insiders that have bought Olin stock in the last two years include Donald W Bogus, Earl L Shipp, John Maurice Sampson, Randall W Larrimore and Scott Mcdougald Sutton. View Insider Buying and Selling for Olin.

Shares of OLN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of OLN stock can currently be purchased for approximately $22.6150.

Olin has a market capitalization of $3.73 billion and generates $6.95 billion in revenue each year. The specialty chemicals company earns $327.90 million in net income (profit) each year or $1.75 on an earnings per share basis. Olin employs 6,500 workers across the globe.

The official website for Olin is http://www.olin.com.

Olin's mailing address is 190 CARONDELET PLAZA SUITE 1530, CLAYTON MO, 63105. The specialty chemicals company can be reached via phone at 314-480-1400 or via email at [email protected]